Date: Fri, 29 Mar 2024 08:10:49 +0100 (CET) Message-ID: <115866904.2421.1711696249549@k5086.pixsoftware.de> Subject: Exported From Confluence MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_Part_2420_2090006023.1711696249549" ------=_Part_2420_2090006023.1711696249549 Content-Type: text/html; charset=UTF-8 Content-Transfer-Encoding: quoted-printable Content-Location: file:///C:/exported.html
This page was last modified on 18 May 2016, at 10:15.
The term eczema may describe a range of persistent skin conditions, incl= uding dryness and recurring skin rashes that are characterized by one or mo= re of these symptoms: redness, skin edema (swelling), itching and dryness, = crusting, flaking, blistering, cracking, oozing, or bleeding.
Donor / recipient
Acceptable if not requiring systemic (i.e. tablet) therapy (including or= al steroids and other immunosuppressive agents). Topical steroids (i.e. cre= ams appied to the skin) are acceptable. Check if given ultraviolet (PUVA) t= herapy, which may otherwise require donor deferral.
Acceptable if not requiring systemic (i.e. tablet) therapy (including or= al steroids and other immunosuppressive agents). Topical steroids (i.e. cre= ams appied to the skin) are acceptable. Check harvest sites are not involve= d (inside elbows, back of hips). Check if given ultraviolet (PUVA) therapy.=
Inform transplant centre if the donor has eczema.
There is a risk of transfer of atopic conditions to the recipient, altho= ugh only a few cases have been described in the literature, and not eczema = specifically. G-CSF may theoretically cause a flare of any inflammatory con= dition, including eczema, although this is likely to return to normal follo= wing donation.
Hallstrand TS, Sprenger JD, Agosti JM, Longton GM, Witherspoon RP, Hende= rson WR, Jr. Long-term acquisition of allergen-specific IgE and asthma foll= owing allogeneic bone marrow transplantation from allergic donors. Blood 20= 04; 104(10): 3086-90.